Fiszdon Joanna M, Dixon H Drew, Davidson Charlie A, Roberts David L, Penn David L, Bell Morris D
VA Connecticut Healthcare System, West Haven, CT, United States.
Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, United States.
Front Psychiatry. 2023 Aug 4;14:1217735. doi: 10.3389/fpsyt.2023.1217735. eCollection 2023.
Given the relationship between social cognition and functional outcome in schizophrenia, a number of social cognitive interventions have been developed, including Social Cognition Interaction Training (SCIT), a group-based, comprehensive, manualized intervention. In the current trial, we examined SCIT efficacy as well as potential moderators of treatment effects. Fifty-one outpatients were randomized to SCIT or a wait-list-control (WLC), with assessments of social cognition, neurocognition, self-report, symptoms, and functioning conducted at baseline and end of the active phase. Relative to WLC, we did not find significant improvements for SCIT on neurocognition, social cognition, self-report, or symptoms, though there was a trend-level, medium effect favoring the SCIT condition on interpersonal and instrumental role function. Post-hoc analyses indicated that baseline neurocognition did not impact degree of social cognitive or functional change. Shorter duration of illness was significantly associated with better post-training neurocognition and self-esteem and, at trend-level with better symptoms and social functioning. We discuss the importance of outcome measure selection and the need for continued evaluation of potential treatment moderators in order to better match people to existing treatments. : Clinicaltrials.gov, Identifier NCT00587561.
鉴于精神分裂症患者的社会认知与功能结局之间的关系,人们已开发出多种社会认知干预措施,包括基于小组的、全面的、手册化的社会认知交互训练(SCIT)。在当前试验中,我们检验了SCIT的疗效以及治疗效果的潜在调节因素。51名门诊患者被随机分为SCIT组或等待名单对照组(WLC),在基线期和急性期结束时对社会认知、神经认知、自我报告、症状和功能进行评估。相对于WLC组,我们未发现SCIT组在神经认知、社会认知、自我报告或症状方面有显著改善,不过在人际和工具性角色功能方面有一个倾向水平的中等效应支持SCIT组。事后分析表明,基线神经认知并未影响社会认知或功能变化的程度。病程较短与训练后更好的神经认知和自尊显著相关,在倾向水平上与更好的症状和社会功能相关。我们讨论了结局指标选择的重要性以及持续评估潜在治疗调节因素的必要性,以便更好地使患者与现有治疗相匹配。:Clinicaltrials.gov标识符NCT00587561。